NCT06368323 Effect of Community Choir Singing in People With Chronic Post-stroke Aphasia
| NCT ID | NCT06368323 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Ottawa |
| Condition | Aphasia |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-04-22 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-04-22 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized controled trial is to test the effects of assigning people with chronic post-stroke aphasia to 12 weekly choir sessions, compared to usual care. The main question it aims to answer is: Does the assignment to a choir singing program causes a beneficial effect on functional communication and language recovery as well as psychosocial outcomes compared to usual care in the rehabilitation of people with chronic post-stroke aphasia? Participants will have: 12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master, and home singing training (3 x 30-minutes-sessions/week, total 18h)
Eligibility Criteria
Inclusion Criteria: * People with chronic aphasia following stroke * English or French as language of daily use * Last stroke must have occurred at least 6 months before the start of the first assessments in the study protocol. Exclusion Criteria: * Regular music making in the past 6 months * Visual deficit that cannot be corrected and might impair testing * Hearing deficit that cannot be corrected and might impair testing * Presence of neurological/psychiatric co-morbidity or substance abuse * No ability to produce vocal sound through singing/humming * Legally considered unable to make decisions for oneself
Contact & Investigator
Anna Zumbansen, PhD
PRINCIPAL INVESTIGATOR
University of Ottawa
Frequently Asked Questions
Who can join the NCT06368323 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aphasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06368323 currently recruiting?
Yes, NCT06368323 is actively recruiting participants. Contact the research team at azumbans@uottawa.ca for enrollment information.
Where is the NCT06368323 trial being conducted?
This trial is being conducted at Tampa, United States, Ottawa, Canada, Toronto, Canada, Montreal, Canada.
Who is sponsoring the NCT06368323 clinical trial?
NCT06368323 is sponsored by University of Ottawa. The principal investigator is Anna Zumbansen, PhD at University of Ottawa. The trial plans to enroll 50 participants.